FGP
CVS icon

Freestone Grove Partners’s CVS Health CVS Stock Holding History

Freestone Grove Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.8M Sell
500,910
-276,792
-36% -$24.7M 0.33% 78
2026
Q1 		$55.9M Sell
777,702
-334,537
-30% -$25.8M 0.39% 71
2025
Q4 		$88.3M Sell
1,112,239
-134,083
-11% -$10.6M 0.64% 22
2025
Q3 		$94M Sell
1,246,322
-1,216
-0.1% -$83.3K 0.7% 18
2025
Q2 		$86.1M Buy
1,247,538
+284,342
+30% +$18.6M 0.65% 29
2025
Q1 		$65.3M Buy
963,196
+156,621
+19% +$9.37M 0.67% 32
2024
Q4 		$36.2M Buy
+806,575
New +$45.2M 0.44% 75

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Freestone Grove Partners's CVS Position: Q2 2026 in Review

Freestone Grove Partners reduced its CVS Health (CVS) stake by 36% in Q2 2026, selling an estimated $24.7M and leaving 500,910 shares worth $51.8M. The position accounts for 0.33% of the portfolio, ranked #78.

Freestone Grove Partners first reported a position in CVS in Q4 2024 and has held it in 7 quarters since. The position peaked at $94M in Q3 2025. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Freestone Grove Partners held 500,910 shares of CVS Health worth $51.8M as of Q2 2026.
  • Freestone Grove Partners sold 276,792 CVS Health shares in Q2 2026, an estimated $24.7M.
  • CVS Health made up 0.33% of Freestone Grove Partners's portfolio in Q2 2026, its #78 holding.
  • Freestone Grove Partners first reported a position in CVS Health in Q4 2024 and has held it in 7 quarters since.
  • Freestone Grove Partners's CVS Health position peaked at $94M in Q3 2025.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.